Success Stories

Copaxone

The first innovative drug to be developed in Israel and to receive FDA approval, Copaxone® is a unique multiple sclerosis immunomodulator: the first and only non-interferon agent for the treatment of relapsing-remitting multiple sclerosis. Copaxone® is licensed to Teva Pharmaceuticals Ltd (Yeda).

DOXIL (Caeylx)

DOXIL is indicated for the treatment of patients with ovarian cancer whose disease has progressed or recurred after platinum-based chemotherapy.

Product developed by; Yechezkal Barenholz, Faculty of Medicine, Hebrew University (Yissum) & Alberto Gabizon, Hadassah University Hospital Jerusalem (Hadasit)

StoreDot

StoreDot is an Israeli lithium-ion battery company based in Herzliya. The company develops batteries that charge significantly faster than conventional li-ion batteries. StoreDot was founded by CEO Doron Myerdorf and his partners in Tel Aviv in 2012.

https://www.store-dot.com/

BrainStorm

BrainStorm is a leader in developing innovative autologous cellular therapies
for highly debilitating neurodegenerative diseases.

https://brainstorm-cell.com/#home-about

Alpha TAU

Alpha Tau Medical was founded in 2016 and focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.

https://www.alphatau.com/about